These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


373 related items for PubMed ID: 18402775

  • 1. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V, Chwalla I, Siess W.
    Biochem Biophys Res Commun; 2008 Jun 13; 370(4):603-8. PubMed ID: 18402775
    [Abstract] [Full Text] [Related]

  • 2. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G, Guba M, Ischenko I, Papyan A, Joka M, Schrepfer S, Bruns CJ, Jauch KW, Heeschen C, Graeb C.
    J Cell Biochem; 2007 May 01; 101(1):259-70. PubMed ID: 17203465
    [Abstract] [Full Text] [Related]

  • 3. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
    LaMontagne K, Littlewood-Evans A, Schnell C, O'Reilly T, Wyder L, Sanchez T, Probst B, Butler J, Wood A, Liau G, Billy E, Theuer A, Hla T, Wood J.
    Cancer Res; 2006 Jan 01; 66(1):221-31. PubMed ID: 16397235
    [Abstract] [Full Text] [Related]

  • 4. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP.
    Ann Neurol; 2008 Jan 01; 63(1):61-71. PubMed ID: 17918267
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
    Clemens JJ, Davis MD, Lynch KR, Macdonald TL.
    Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3568-72. PubMed ID: 15982878
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
    Kohno T, Igarashi Y.
    Genes Cells; 2008 Jul 01; 13(7):747-57. PubMed ID: 18513330
    [Abstract] [Full Text] [Related]

  • 7. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH, Rochwalsky U, Reinhold J, Seeger F, Aicher A, Urbich C, Spyridopoulos I, Chun J, Brinkmann V, Keul P, Levkau B, Zeiher AM, Dimmeler S, Haendeler J.
    Arterioscler Thromb Vasc Biol; 2007 Feb 01; 27(2):275-82. PubMed ID: 17158356
    [Abstract] [Full Text] [Related]

  • 8. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y, Seki N, Sato N, Sugahara K, Chiba K.
    Int Immunol; 2010 Jun 01; 22(6):515-25. PubMed ID: 20497959
    [Abstract] [Full Text] [Related]

  • 9. Sphingosine signalling regulates decidual NK cell angiogenic phenotype and trophoblast migration.
    Zhang J, Dunk CE, Lye SJ.
    Hum Reprod; 2013 Nov 01; 28(11):3026-37. PubMed ID: 24001716
    [Abstract] [Full Text] [Related]

  • 10. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A, Pfeilschifter J.
    Biochem Pharmacol; 2008 May 15; 75(10):1893-900. PubMed ID: 18321471
    [Abstract] [Full Text] [Related]

  • 11. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K, Matsuyuki H, Maeda Y, Sugahara K.
    Cell Mol Immunol; 2006 Feb 15; 3(1):11-9. PubMed ID: 16549044
    [Abstract] [Full Text] [Related]

  • 12. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor.
    Whetzel AM, Bolick DT, Srinivasan S, Macdonald TL, Morris MA, Ley K, Hedrick CC.
    Circ Res; 2006 Sep 29; 99(7):731-9. PubMed ID: 16960101
    [Abstract] [Full Text] [Related]

  • 13. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K.
    Pharmacol Ther; 2005 Dec 29; 108(3):308-19. PubMed ID: 15951022
    [Abstract] [Full Text] [Related]

  • 14. Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds.
    Tölle M, Levkau B, Kleuser B, van der Giet M.
    Eur J Clin Invest; 2007 Mar 29; 37(3):171-9. PubMed ID: 17359484
    [Abstract] [Full Text] [Related]

  • 15. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY, Tokita D, Wang Z, Wang HC, Zhan J, Brinkmann V, Thomson AW.
    Transpl Immunol; 2008 Nov 29; 20(1-2):88-94. PubMed ID: 18694829
    [Abstract] [Full Text] [Related]

  • 16. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice.
    Bolick DT, Srinivasan S, Kim KW, Hatley ME, Clemens JJ, Whetzel A, Ferger N, Macdonald TL, Davis MD, Tsao PS, Lynch KR, Hedrick CC.
    Arterioscler Thromb Vasc Biol; 2005 May 29; 25(5):976-81. PubMed ID: 15761190
    [Abstract] [Full Text] [Related]

  • 17. Roles of extracellular and intracellular sphingosine 1-phosphate in cell migration.
    Yu H, Okada T, Kobayashi M, Abo-Elmatty DM, Jahangeer S, Nakamura S.
    Genes Cells; 2009 May 29; 14(5):597-605. PubMed ID: 19371379
    [Abstract] [Full Text] [Related]

  • 18. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Keul P, Tölle M, Lucke S, von Wnuck Lipinski K, Heusch G, Schuchardt M, van der Giet M, Levkau B.
    Arterioscler Thromb Vasc Biol; 2007 Mar 29; 27(3):607-13. PubMed ID: 17158351
    [Abstract] [Full Text] [Related]

  • 19. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
    Butler J, Lana D, Round O, LaMontagne K.
    Prostaglandins Other Lipid Mediat; 2004 Jan 29; 73(1-2):29-45. PubMed ID: 15165029
    [Abstract] [Full Text] [Related]

  • 20. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, van Berkel T, Assmann G, Biessen EA.
    Circulation; 2007 Jan 30; 115(4):501-8. PubMed ID: 17242282
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.